Atlas Trials

Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis

Clinical trial NCT03113162 · UNKNOWN

Trial details

NCT number
NCT03113162
Sponsor
Makati Medical Center
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2015-05-29
Primary completion
2020-05-29
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.